Georgetown's Cancer Center Awarded Top Designation by National Cancer Institute; Comprehensive Cancer Center Consortium Includes Hackensack Meridian's John Theurer Cancer Center onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
BioXcel Therapeutics Announces Completion of Patient Enrollment in Safety Portion of Investigator-Sponsored Phase 2 Relapsed Pancreatic Cancer Trial of BXCL701 in Combination with KEYTRUDA® tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The annual Edward M. Kovach Cura Personalis Endowed Lecture celebrates the principle of cura personalis, or “care for the whole person,” and honors the legacy of Mr. Edward M. Kovach. Mr. Kovach attended Georgetown University for both his undergraduate and law degrees, and after serving as an officer in the United States Coast Guard he […]
Jounce Therapeutics (NASDAQ:JNCE – Get Rating) and Kymera Therapeutics (NASDAQ:KYMR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations. Institutional & Insider Ownership 80.7% of Jounce Therapeutics shares […]